Responsum Health is working with its partners to provide our members access to breakthrough clinical trials. Clinical trials play a vital role in discovering new, viable treatment options for both acute and chronic diseases. Read more about each trial below to see if you are eligible.
The goal of this study is to see if an experimental drug, called ADX-629, is safe and can help prevent relapses and improve symptoms of nephrotic syndrome.
We Value Your Privacy
We use cookies to improve your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept All”, you consent to our use of cookies.
Cookies are small bits of information that we might place on your computer. We use them to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
You can program your computer to warn you each time a cookie is being sent, block third party cookies or block all cookies. However, by blocking all cookies you may not have access to certain features of the service. To learn more visit our Privacy Policy page.